Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Complement components and their activation products in pleural fluid

E R Salomaa1, M Viander, T Saaresranta

  • 1Department of Pulmonary Diseases and Clinical Allergology, Turku University Hospital, Finland. eirisa@utu.fi

Chest
|September 22, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sleep apnoea phenotypes in women: A cluster analysis from the ESADA cohort.

Sleep medicine·2024
Same author

Response to the letter entitled "Which treatments are effective in preventing motor vehicle accidents in patients with obstructive sleep apnea?"

Sleep & breathing = Schlaf & Atmung·2023
Same author

Insomnia symptoms combined with nocturnal hypoxia associate with cardiovascular comorbidity in the European sleep apnea cohort (ESADA).

Sleep & breathing = Schlaf & Atmung·2018
Same author

The European Sleep Apnoea Database (ESADA): report from 22 European sleep laboratories.

The European respiratory journal·2011
Same author

Management of obstructive sleep apnea in Europe.

Sleep medicine·2010
Same author

Transcutaneous carbon dioxide profile during sleep reveals metabolic risk factors in post-menopausal females.

The European respiratory journal·2009
Same journal

Wearable-derived activity and physiological changes following pleural intervention in malignant pleural effusion.

Chest·2026
Same journal

The effect of a two-day stay at high altitude (2500 m) on right ventricular afterload and oxygen delivery in patients with pulmonary vascular disease A randomized controlled crossover trial.

Chest·2026
Same journal

A Comparative Study of Radiation Exposure in Conventional and Robotic Bronchoscopy.

Chest·2026
Same journal

Independent Prognostic Contributions of Anti-Ro52 and Anti-MDA5 in Autoimmune-Associated Interstitial Lung Disease.

Chest·2026
Same journal

Lung aeration and gas exchange in SGA or AGA infants with moderate-severe BPD: secondary analysis of the PATH-BPD study.

Chest·2026
Same journal

Lung Cancer Incidence and Mortality after Negative Low-Dose CT Screening Results.

Chest·2026
See all related articles

Complement activation markers, specifically soluble C5b-9, can differentiate rheumatic pleural effusion from malignant or tuberculous causes. Analysis of complement components aids in diagnosing pleural effusion etiologies.

Area of Science:

  • Immunology
  • Pulmonology
  • Biochemistry

Background:

  • Pleural effusion diagnosis can be challenging.
  • Complement system activation plays a role in inflammatory processes.
  • Novel markers of complement activation may improve diagnostic accuracy.

Purpose of the Study:

  • To investigate the role of complement components in pleural effusion.
  • To identify predominant complement activation pathways in different pleural effusion etiologies.
  • To assess the utility of complement markers in differentiating pleural effusion causes.

Main Methods:

  • Analyzed complement components and activation products (SC5b-9) in plasma and pleural fluid.
  • Studied 71 patients with pleural effusion due to tuberculosis, rheumatic disease, or malignancy.

Related Experiment Videos

  • Utilized stepwise multinomial logistic regression for predictor analysis.

    • Main Results:

    • Pleural fluid SC5b-9 levels distinguished rheumatic from malignant effusions.
    • Rheumatic effusions showed higher SC5b-9 and C1s-C1r-C1INH-complexes, with lower C3/C4 and higher C4d/C4 ratio.
    • High pleural fluid SC5b-9 and low C4 were key predictors for rheumatic pleural fluid.

    Conclusions:

    • Complement cascade is activated via both classic and alternative pathways in rheumatic pleurisy.
    • SC5b-9 and C4d/C4 ratio effectively differentiate rheumatic, tuberculous, and malignant effusions.
    • Complement analysis offers a valuable tool for diagnosing pleural effusion.